- Science
- Global
Undergrads expand the chemical toolbox for cancer drugs
- February 26, 2026 at 11:30 PM
- 4 views
Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from unwanted side effects and limited efficacy. In a recent Bioconjugate Chemistry publication, William & Mary researchers have designed an antibody-drug conjugate (ADC) with the potential to improve the potency and decrease the cost of currently approved cancer drugs.
Originally published at Phys.org